260321 Access and utilization of healthcare among infants with mothers in Methadone Maintenance Treatment in Taiwan

Monday, October 29, 2012

Shao-You Fang, MSc , Institute of Public Health, National Yang-Ming University, Taipei, Taiwan
Hsueh-Han Yeh, MSc , Division of Mental Health & Addiction Medicine, National Health Research Institutes, Miaoli County, Taiwan
Kuang-Hung Chen, MSc , Institute of Public Health, National Yang-Ming University, Taipei, Taiwan
Lien-Wen Su, MD , Department of Addiction Science, Taipei City Hospital, Songde Branch, Taipei, Taiwan
Chia-Hsiang Chen, MD, PhD , Division of Mental Health & Addiction Medicine, National Health Research Institutes, Miaoli County, Taiwan
Ing-Kang Ho, PhD , China Medical University Hospital, Center of Addiction Medicine, Taichung city, Taiwan
Chuan-Yu Chen, PhD , Institute of Public Health, National Yang-Ming University, Taipei, Taiwan
Objective: This study investigated the insurance coverage for offspring of mothers in the Methadone Maintenance Treatment (MMT) and examined the relationships between infant's preventive service and curative care utilization with maternal illegal drug treatment history.

Methods: Data were obtained from the national MMT database, the National Birth Notification and Registration Databases, and the National Health Insurance Research Database. Through data linkage, we identified 199 infants with mothers in the MMT, and 1:10 controls matching on birth year (2006-2008), maternal age, and socioeconomic status (primarily lower SES); 258 were identified as the other control group when their non-MMT enrolled mothers had illegal drug problems visits (ICD-9CM code: 304, 305) within the year prior to delivery. Logistic and two-part regression models were employed to evaluate the association estimates.

Results: Even when national health insurance is enforced, only 54% of children with mothers in the MMT received continued insurance coverage in the first year of life. With potential confounders adjusted, infants with MMT enrolled mothers were at 1.4-fold risk to have no/discontinued health insurance (P < 0.01) as compared to those with matched mothers; the visits for well-baby preventive service and curative healthcares were significantly lowered (β=-0.45 and -0.01). Relationship estimates were slightly greater when in comparison with those born to drug-using control (adjusted Odds Ratio=2.3; β=-0.40, -0.83, Ps<.001).

Conclusion: Harm reduction programs for women with child-bearing ages should be delivered in coordinated care systems that ensure the comprehensiveness and continuum in healthcare, child welfare, and social service.

Learning Areas:
Public health or related public policy
Social and behavioral sciences

Learning Objectives:
Describe and compare the access and utilization of healthcare among infants with different maternal drug treatment history

Keywords: Drug Abuse Treatment, Access to Health Care

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have participated in multiple nationally funded grants focusing on the epidemiology of drug abuse, mental and drug-use disorders, and health of women and children in methadone maintenance treatment.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

Back to: 3077.0: ATOD Student Poster Showcase